TD Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCE
CC
MF
BCM
FCM
TD Asset Management's ONCE Position: Q1 2019 in Review
TD Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 47,766 shares — an estimated $1.87M sold.
TD Asset Management first reported a position in ONCE in Q1 2015 and held it in 16 quarters. The position peaked at $7.15M in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.
- TD Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
- TD Asset Management sold 47,766 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $1.87M.
- TD Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 16 quarters.
- TD Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $7.15M in Q3 2017.
- 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.
Based on TD Asset Management's 13F filing for Q1 2019, filed 8 May 2019.